针对周血管细胞的炎症和神经免疫相互作用,用于治疗病
1Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. shitanaka@m.u-tokyo.ac.jp.
Clinical and experimental nephrology
|April 17, 2024
概括
周血管细胞通过血管粘附蛋白-1和斯芬戈-1-酸盐 (S1P) 信号传递驱动炎症. 针对这些途径和探索神经免疫相互作用为病治疗提供了新的策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 脏炎症是脏疾病病理生理学的核心.
- 周血管细胞是促进炎症和免疫细胞透的关键参与者.
- 血管粘附蛋白-1 (VAP-1) 和斯芬戈-1-酸盐 (S1P) 信号传导与周血管炎症有关.
研究的目的:
- 研究VAP-1和S1P信号在周血管炎症中的作用.
- 探索针对这些途径和神经免疫相互作用治疗脏疾病的治疗潜力.
主要方法:
- 对VAP-1的酶活性测定.
- 对S1P运输和受体结合的分析.
- 对低氧诱导因子-酸酶抑制剂的研究.
- 参与迷走神经刺激诱导脏保护的神经通路的映射.
主要成果:
- 阻断VAP-1降低了过氧化的产生和中性粒细胞的透,减轻了缺血-再输液损伤.
- 通过spinster同源2抑制S1P传输,降低了纤维化.
- 催氧诱导因子-基酶抑制剂显示出缓解炎的潜力.
- 阴道 afferents-C1神经元-交感神经系统-脏神经-脏-脏轴被确定为关键的阴道神经刺激诱导的脏保护.
结论:
- 周血管细胞中的VAP-1和S1P信号通路是炎和纤维化的关键调节者.
- 针对VAP-1和S1P传输,为脏疾病提供了有前途的治疗途径.
- 神经免疫调节,特别是通过迷走神经刺激,为脏保护提供了一种新的策略.
- 需要进一步的研究来充分阐明炎控制系统,并将研究结果转化为临床实践.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
136
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
136


